This reduced tumor aggressiveness was accompanied, and possibly secondary to, a marked remodeling of the TME, which after CD74 ectopic expression was not significantly different between IRF8 WT and IRF8 mutant lymphomas. This evidence concerns the gene IRF8 and lymphoma.